MetaVia, Inc. (MTVA)
1.41
-0.07
(-4.73%)
USD |
NASDAQ |
Mar 20, 16:00
1.40
-0.01
(-0.71%)
After-Hours: 20:00
MetaVia Research and Development Expense (Quarterly) : 1.914M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Aethlon Medical, Inc. | 0.5328M |
| Tonix Pharmaceuticals Holding Corp. | 16.94M |
| Phio Pharmaceuticals Corp. | 1.477M |
| Jaguar Health, Inc. | 3.658M |
| Seastar Medical Holding Corp. | 1.85M |